Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Total 13F shares
-
74,643,254
-
Share change
-
+2,102,386
-
Total reported value
-
$2,005,663,054
-
Put/Call ratio
-
72%
-
Price per share
-
$26.87
-
Number of holders
-
253
-
Value change
-
+$41,168,266
-
Number of buys
-
106
-
Number of sells
-
131
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q3 2023
As of 30 Sep 2023 ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) had 253 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 74,643,254 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, FMR LLC, JPMORGAN CHASE & CO, Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, Rokos Capital Management LLP, CREDIT SUISSE AG/, and NORTHERN TRUST CORP.
This table shows 253 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.